Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2642321000168115 | Acamprosate (Apotex) (acamprosate calcium 333 mg) enteric tablet, 180 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2642331000168117 | Acamprosate (Apotex) 333 mg enteric tablet, 180 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acamprosate (Apotex) 333 mg enteric tablet, 180 | Is a | acamprosate calcium 333 mg enteric tablet, 180 | true | Inferred relationship | Some | ||
| Acamprosate (Apotex) 333 mg enteric tablet, 180 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Acamprosate (Apotex) 333 mg enteric tablet, 180 | has TPUU | Acamprosate (Apotex) 333 mg enteric tablet | true | Inferred relationship | Some | 1 | |
| Acamprosate (Apotex) 333 mg enteric tablet, 180 | has TP | Acamprosate (Apotex) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Acamprosate (Apotex) 333 mg enteric tablet, 180, blister pack | Is a | True | Acamprosate (Apotex) 333 mg enteric tablet, 180 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR